Status:
UNKNOWN
Real Life Study in Myopic Neovascularization
Lead Sponsor:
Poitiers University Hospital
Conditions:
Myopic Choroidal Neovascularisation
Eligibility:
All Genders
18-99 years
Brief Summary
This is a multi centre, single arm, prospective observational phase 4 study in naive or pretreated patients with myopic neovascularization. The patients will be treated with intravitreal injections of...
Eligibility Criteria
Inclusion
- Man or woman aged 18 years and more under reliable method of contraception for woman with childbearing potenteial (hormonal or any intrauterine devices).
- High myopy defined by refractive error ≤ -6 D or History of high myopia among pseudophakic patient or patient treated with refractive surgery
- Patient with active CNVm
- • Patients naïve or Patients pretreated with previous history of laser photocoagulation or PDT or by other anti-VEGF treatments who did not receive injection since the last 3 month
- with OCT or angiography examination
Exclusion
- Treatment with an anti VEGF administrated by intravitreal injection within 1 months prior to baseline in the study eye.
- Treatment with PDT or laser administrated within 6 months prior to baseline in the study eye.
- History of vitrectomy in the study eye
- History of any other retinal disease
- VA less than 20/250
Key Trial Info
Start Date :
June 22 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03797547
Start Date
June 22 2018
End Date
January 30 2023
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Poitiers
Poitiers, France